FatLiverDoc

Liver doctor specializing in the treatment of fatty liver disease and obesity.

[FatLiverDoc @LiverFat]

@liverUSA So very sad for his family, such a terrible loss for the Chicago liver family and the hepatology community as well.

[FatLiverDoc @LiverFat]

@Rush_GI @ZoePostMD @aryannasousaMD @AASLDtweets @AASLDFoundation @NancyReau Amazing job by an amazing team with an amazing mentor!

[Rush Gastroenterology and Hepatology Fellowship @Rush_GI]

So proud of our 3rd year fellow @ZoePostMD and transplant hepatology fellow @aryannasousaMD on their excellent presentations/arguments for the academic debate at The Liver Meeting! Great job! 👏🏻��� #TLM24 @AASLDtweets @AASLDFoundation

[Elliot Tapper @ebtapper]

Have you ever wondered ... how beta-blockers treat #cirrhosis?

Here's a #tweetorial featuring:
1⃣Pathophys!
2⃣controversy!
3⃣Cheap, life-saving interventions!

#livertwitter #gitwitter #meded

1/

[FatLiverDoc @LiverFat]

MASLD: Promising Treatments for a Newly Renamed Disease https://t.co/5Ire5gSfpe via @medscape

[Michael Doyen "Group 2" @MichaelDoyen3]

@ALFGreatLakes Debates

[FatLiverDoc @LiverFat]

All’s good at the @AlfDebates . Great debate on whether a mandatory lifestyle intervention should be instituted for patients being transplanted for NASH. Important and nuanced topic!

[FatLiverDoc @LiverFat]

@gscottwinder I haven’t much time researching the actual assay to see how the values are calculated, but I believe there is a rough correlation although I am not sure it is a linear one. I say this based on my loose correlations between with level of reported etOH intake and PeTh level.

[FatLiverDoc @LiverFat]

@gscottwinder Then I interpret the test like I was still a lab scientist... interpret the number in context, not the lab given cutoffs.

[FatLiverDoc @LiverFat]

@gscottwinder I tell people the test I am running is not supposed to be positive with a single slip but rather from repeated chronic significant alcohol use. This is a way for them to know if the amount they are exposed to if any is too much. But tell them I believe them if they say it’s none.

[FatLiverDoc @LiverFat]

@MikeAlbertMD A cornerstone of #obesitymedicine @OMAsocial @ObesitySociety @ObesityMedicine

[Michael Albert, MD @MichaelAlbertMD]

Why therapeutic low-carb + HP is so effective in T2DM:

Graph A: washout diet vs ADA diet (Carb 55%, Protein 15%, Fat 30%)

Graph B: washout diet vs therapeutic low-carb + HP (Carb 20%, Protein 30%, Fat 50%)

*Glycemic control is superior with low-carb (non-keto) + high protein*

[FatLiverDoc @LiverFat]

@AtoosaRabiee @rrosenblattmd @BloomPringle @ebtapper @AutoImmuneLiver @serperm @DrLiver Sarcoid with normal alk phos?....
suspicious.

[FatLiverDoc @LiverFat]

@AtoosaRabiee @SultanMahmoodMD @GiJournal @MaureenWhitsett @liverazzi @ebtapper @ArpanPatelMD @JBenhammouMD @BloomPringle @JonathanStineMD @gnioannou @drkeithsiau @Will_Sanchez_MD @BWSadowskiMD @SanchezLunaMD @AhmadBazarbashi completely agree. you just said it better :)

https://t.co/o5fQopzR83

[FatLiverDoc @LiverFat]

@GiJournal @AtoosaRabiee @mqkMD @ijlalakbar @SultanMahmoodMD @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo Though it predicts HRS development, does diminished cardiac reserve alone justify prioritization for transplant if diminished cardiac reserve does not predict transplant-free survival and did not impact survival in those that did not develop HRS?

[FatLiverDoc @LiverFat]

@AtoosaRabiee @SultanMahmoodMD @GiJournal @MaureenWhitsett @liverazzi @ebtapper @ArpanPatelMD @JBenhammouMD @BloomPringle @JonathanStineMD @gnioannou @drkeithsiau @Will_Sanchez_MD @BWSadowskiMD @SanchezLunaMD @AhmadBazarbashi agreed, I think that once you have HRS and are likely on chronic midodrine therapy, NSBB are out. but agreed, maybe this is another clinical characteristic (with SBP, refractory ascites) that should lead to hold BB. but again, need mortality data.

[FatLiverDoc @LiverFat]

@AtoosaRabiee agreed, but in the end, this study just shows that as they get sicker, they are more likely to get cirrhotic cardiomyopathy. The "new" (quotes intentional) thing was that cirrhotic cardiomyopathy predicts HRS. but like you said.. does it change ur mgmt.

[FatLiverDoc @LiverFat]

@MTPapaD @AtoosaRabiee @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP Ha. yes, but that being said, say "ANSWER" study, and you know it. Ask which hep C study was the CORAL study? probably not a fair comparison as there are not 10,000 albumin studies in the past decade.

[FatLiverDoc @LiverFat]

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP ANSWER was amazing, to find similar results in patients with refractory ascites was the icing on the cake. truly disease modifying therapy.

[FatLiverDoc @LiverFat]

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP shoot. I just realized that question may have been for the trainees. SORRY!

[FatLiverDoc @LiverFat]

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP absolutely, in a study of patients with refractory ascites, outpatient albumin infusion reduced the incidence of HRS